ag 112 has been researched along with b 43 in 3 studies
| Studies (ag 112) | Trials (ag 112) | Recent Studies (post-2010) (ag 112) | Studies (b 43) | Trials (b 43) | Recent Studies (post-2010) (b 43) |
|---|---|---|---|---|---|
| 19 | 0 | 10 | 29 | 0 | 17 |
| Protein | Taxonomy | ag 112 (IC50) | b 43 (IC50) |
|---|---|---|---|
| Chain A, Tyrosine-protein kinase BTK | Homo sapiens (human) | 0.0007 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 1.6885 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.1703 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.126 | |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.42 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.315 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 2.5267 | |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | 5.18 | |
| Angiopoietin-1 receptor | Homo sapiens (human) | 4.3433 | |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | 0.31 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
3 other study(ies) available for ag 112 and b 43
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |